- Home
- LTC vs CNTA Comparison
LTC vs CNTA Comparison
Compare LTC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- CNTA
- Stock Information
- Founded
- LTC 1992
- CNTA 2020
- Country
- LTC United States
- CNTA United Kingdom
- Employees
- LTC N/A
- CNTA N/A
- Industry
- LTC Real Estate Investment Trusts
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- CNTA Health Care
- Exchange
- LTC Nasdaq
- CNTA Nasdaq
- Market Cap
- LTC 1.6B
- CNTA 1.6B
- IPO Year
- LTC 1992
- CNTA 2021
- Fundamental
- Price
- LTC $35.28
- CNTA $14.29
- Analyst Decision
- LTC Hold
- CNTA Strong Buy
- Analyst Count
- LTC 5
- CNTA 10
- Target Price
- LTC $37.80
- CNTA $28.78
- AVG Volume (30 Days)
- LTC 355.4K
- CNTA 992.4K
- Earning Date
- LTC 07-28-2025
- CNTA 08-12-2025
- Dividend Yield
- LTC 6.52%
- CNTA N/A
- EPS Growth
- LTC 0.36
- CNTA N/A
- EPS
- LTC 1.93
- CNTA N/A
- Revenue
- LTC $202,686,000.00
- CNTA $15,000,000.00
- Revenue This Year
- LTC N/A
- CNTA N/A
- Revenue Next Year
- LTC $11.33
- CNTA N/A
- P/E Ratio
- LTC $18.29
- CNTA N/A
- Revenue Growth
- LTC 3.98
- CNTA 118.88
- 52 Week Low
- LTC $31.70
- CNTA $9.00
- 52 Week High
- LTC $39.89
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- LTC 51.84
- CNTA 61.38
- Support Level
- LTC $34.90
- CNTA $13.22
- Resistance Level
- LTC $35.81
- CNTA $14.74
- Average True Range (ATR)
- LTC 0.55
- CNTA 0.73
- MACD
- LTC 0.05
- CNTA 0.14
- Stochastic Oscillator
- LTC 66.83
- CNTA 85.11
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.